Back to Search Start Over

Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care.

Authors :
Fu, Edouard L
Levey, Andrew S
Coresh, Josef
Grams, Morgan E
Faucon, Anne-Laure
Elinder, Carl-Gustaf
Dekker, Friedo W
Delanaye, Pierre
Inker, Lesley A
Carrero, Juan-Jesus
Source :
Nephrology Dialysis Transplantation; Apr2024, Vol. 39 Issue 4, p694-706, 13p
Publication Year :
2024

Abstract

Background New equations to estimate glomerular filtration rate based on creatinine (eGFR<subscript>cr</subscript>), cystatin C (eGFR<subscript>cys</subscript>) or both (eGFR<subscript>cr-cys</subscript>) have been developed by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and the European Kidney Function Consortium (EKFC). There is a need to evaluate the performance of these equations in diverse European settings to inform implementation decisions, especially among people with key comorbid conditions. Methods We performed a cross-sectional study including 6174 adults referred for single-point plasma clearance of iohexol in Stockholm, Sweden, with 9579 concurrent measurements of creatinine and cystatin C. We assessed the performance of the CKD-EPI 2009/2012/2021, EKFC 2021/2023, revised Lund-Malmö (RLM) 2011 and Caucasian, Asian, Pediatric and Adult (CAPA) 2014 equations against measured GFR (mGFR). Results Mean age was 56 years, median mGFR was 62 mL/min/1.73 m<superscript>2</superscript> and 40% were female. Comorbid conditions were common: cardiovascular disease (30%), liver disease (28%), diabetes (26%) and cancer (26%). All eGFR<subscript>cr-cys</subscript> equations had small bias and P<subscript>30</subscript> (the percentage of estimated values within 30% of mGFR) close to 90%, and performed better than eGFR<subscript>cr</subscript> or eGFR<subscript>cys</subscript> equations. Among eGFR<subscript>cr</subscript> equations, CKD-EPI 2009 and CKD-EPI 2021 showed larger bias and lower P<subscript>30</subscript> than EKFC 2021 and RLM. There were no meaningful differences in performance across eGFR<subscript>cys</subscript> equations. Findings were consistent across comorbid conditions, and eGFR<subscript>cr-cys</subscript> equations showed good performance in patients with liver disease, cancer and heart failure. Conclusions In conclusion, eGFR<subscript>cr-cys</subscript> equations performed best, with minimal variation among equations in this Swedish cohort. The lower performance of CKD-EPI eGFR<subscript>cr</subscript> equations compared with EKFC and RLM may reflect differences in population characteristics and mGFR methods. Implementing eGFR<subscript>cr</subscript> equations will require a trade-off between accuracy and uniformity across regions. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09310509
Volume :
39
Issue :
4
Database :
Complementary Index
Journal :
Nephrology Dialysis Transplantation
Publication Type :
Academic Journal
Accession number :
176248503
Full Text :
https://doi.org/10.1093/ndt/gfad219